EurekaMag.com logo
+ Translate

Investigation on platelet aggregation of dauricine in patients with cardiovascular diseases


, : Investigation on platelet aggregation of dauricine in patients with cardiovascular diseases. Chinese Pharmacological Bulletin 10(1): 33-36

Dauricine is a new antiarrhythmic compound isolated from Menispermum dauricum rhizomes. Dauricine markedly inhibited aggregation of human platelets induced by ADP and other substances in vitro in a dose-dependent manner. A 20-30% inhibition of platelet aggregation was achieved after oral administration of 300 mg dauricine, 3 times a day, for 21 days, to 22 patients with coronary heart disease.

(PDF 0-2 workdays service)

Accession: 002416990

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Liu J.; Qiu P., 1986: Effect of dauricine on platelet aggregation in rabbits. It has been shown that dauricine possesses antiarrhythmic and hypotensive actions. Our experimentation demonstrates that dauricine inhibits platelet aggregation induced by the threshold concentration of adenosine diphosphate (ADP), arachidonic aci...

Liu Yu, Z.Y.juan; Shen Yuzhang, 1995: Effects of dauricine and daurisoline on platelet aggregation and adhesion. Our experiment showed that dauricine and daurisoline could inhibit platelet aggregation induced by several agonists in vitro. The IC-50 of dauricine to platelet aggregation stimulated by ADP, AA and collagen was 0.042, 0.028 and 0.045 mmol/L, and...

D.C.ee, J.; Leempoels, J.; Demoen, B.; Roels, V.; Verhaegen, H., 1985: The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases. Platelet aggregation in response to 5-hydroxytryptamine was investigated in 40 normal subjects, in 45 patients with acute myocardial infarction, and in 65 patients with peripheral arterial obstructive disease. It was found that of the 110 patients...

Tong, L.; Yue, T.L., 1989: Effect of dauricine on rat and human platelet aggregation and metabolism of arachidonic acid in washed rat platelets. Dauricine (Dau), an isoquinoline alkaloid extracted from the roots of Menispermum dauricum D. C. and used as an antiarrhythmic agent in China recently, was shown to inhibit rat platelet aggregation induced by arachidonic acid (AA) and ADP, as well...

D.C.ee J.; Leempoels J.; Demoen B.; Roels V.; Verhaegen H., 1985: The effect of ketanserin a 5 hydroxytryptamine 2 receptor antagonist on 5 hydroxytryptamine induced irreversible platelet aggregation in patients with cardiovascular diseases. Platelet aggregation in response to 5-hydroxytryptamine was investigated in 40 normal subjects, in 45 patients with acute myocardial infarction, and in 65 patients with peripheral obstructive disease. It was found that of the 110 patients with car...

Boeynaems, J.M., 1982: Prevention of cardiovascular diseases by inhibitors of platelet aggregation. Revue Medicale de Bruxelles 3(6): 415-424

Peng Li; Zhang Guangyin; Ding Yi; Cao Yang; Zhang Junping, 2011: Role of Platelet-Monocyte Aggregation in the Onset of Acute Cardiovascular and Cerebrovascular Diseases. Atherosclerosis is the main pathological basis of cardiovascular and cerebrovascular diseases. Adhesion and aggregation of platelet and monocyte play an important role in patients with acute cardiovascular and cerebrovascular diseases. This articl...

Cunietti, E.; Gandini, R.; Mascaro, G.; Ferrari, M.; Pappalepore, V.; Scapellato, L., 1981: Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases. In 9 patients with myeloproliferative diseases (MPD) (6 with myelofibrosis, MF, 1 with Ph1 positive chronic granulocytic leukaemia, CGL, 1 with primary eosinophilia, PE, 1 with pre-leukaemia syndrome, preL) collagen, epinephrine, and ADP-induced a...

Scharrer I.; Pander U., 1977: Factor viii associated antigen platelet retention and platelet aggregation in patients with vascular diseases. Thrombosis & Haemostasis 38(1): 336

Levi, J.; Bicher, H.I.; Rosenfeld, J., 1970: Platelet aggregation in several cardiovascular diseases determined with a modified screen filtration pressure method. Journal of Medicine 1(3): 132-141